From 1990 to 2021, China experienced faster declines in standardized smoking burden than the global average, yet its absolute burden and global share increased substantially, suggesting sustained, targeted tobacco control-especially among older males and for cancer prevention-is urgently needed.
Abstract
INTRODUCTION
Smoking remains one of the leading preventable causes of morbidity and mortality worldwide. Understanding long-term trends in smoking-related diseases is essential for evaluating policy effectiveness and guiding prevention efforts. This study assessed the burden of disease attributable to smoking in China from 1990 to 2021, comparing its trends with global and sociodemographic index (SDI) patterns to identify policy priorities.
Methods
Age-, sex-, and SDI-stratified analyses were conducted using mortality and disability-adjusted life years (DALYs) data from the Global Burden of Disease Study 2021. Temporal trends were evaluated with Joinpoint regression and multiple visualization methods.
Results
Globally, age-standardized smoking-attributable death rates declined, but China showed a steeper decline (average annual percent change = -2.00 vs. -1.77). However, China's absolute smoking-related deaths rose by 57.5% to 2.30 million in 2021, accounting for 37.3% of the global total. Males bore a disproportionately higher burden, with an age-standardized death rate nearly 10 times that of females. Burden peaked at ages 65-74 for death counts and at ages 90-94 for rates. Unlike the global pattern where cardiovascular diseases dominate, neoplasms were the leading cause in China. Age-standardized DALYs rates for diabetes and kidney diseases showed a rising trend.
Conclusion
From 1990 to 2021, China experienced faster declines in standardized smoking burden than the global average, yet its absolute burden and global share increased substantially. Sustained, targeted tobacco control-especially among older males and for cancer prevention-is urgently needed.
Introduction Smoking is a well-established risk factor for digestive diseases, yet direct comparisons of smoking-attributable digestive disease burden between nations with divergent tobacco control trajectories remain scarce. This study compared temporal trends, driving factors, and future projections of this burden in...
Zhuo-Fu Cheng, Xue Luo, Da Yan et al.· Tobacco Induced Diseases· 0 citations
Although China has substantially reduced occupational disease burden, chronic conditions and vulnerable populations require greater attention through targeted strategies through targeted strategies.
H. Lou, Ji-Mian Zhang, Xin Wang et al.· Journal of Occupational and...· 0 citations
Objectives Tobacco use remains a major contributor to mortality and disability in India. This study assessed tobacco-attributable mortality and disability-adjusted life-years (DALYs) in India in 1990 and 2023, with comparisons by sex, age group and type of tobacco exposure. Design Descriptive population-level analysis...
Global and Chinese overall stroke age-standardized incidence rates declined, but new cases increased globally, and ischemic stroke age-standardized incidence rose significantly in China, and China's proportion of global cases and deaths decreased.
Fei-Hong Hu, Hai-Lin Lu, Hong Xu et al.· Neuroepidemiology· 0 citations
Asthma mortality in China has declined substantially, but the nonfatal burden continues to rise, driven by increasing prevalence and metabolic risk factors.
Zhuo Wang, Yi-Ding Zhuang, Jin-Lei Qi et al.· Chinese Medical Journal· 0 citations
BACKGROUND
Stroke remains a major cause of death and disability in China. We assessed whether declining fatal burden was accompanied by improvement in non-fatal disability and characterized updated attributable risks.
METHODS
Global Burden of Disease Study 2023 estimates for China during 1990-2023 were analyzed for a...
Hong-Jian Wen, Xiao-Rong Jiang, Cui-Xiu Qin et al.· Journal of Stroke & Cerebrov...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.